Accel Research Sites

Maitland, Florida 32751

0 studies enrolling now · 9 studies all time

What they study most

ADHD, ADHD - Combined Type, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity, COVID-19 Disease, Influenza, NASH - Nonalcoholic Steatohepatitis, Post Traumatic Stress Disorder, SARS-CoV-2

Studies at this site

• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 — Paused
• A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) — Running, not enrolling
• A Study to Assess the Use of Methylone in the Treatment of PTSD — Completed
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults — Completed
• Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
• Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents) — Completed
• Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult) — Completed